Manx Financial CEO on Conister Bank’s partnership with Fiinu (LON:MFX)
25 September 2025
Zeus Capital Director of Healthcare Research Dr Gary Waanders caught up with DirectorsTalk for an exclusive interview to discuss Allergy Therapeutics plc (LON:AGY) Q1: Now, Allergy Therapeutics announced today..
Allergy Therapeutics Plc (LON:AGY) is the topic of conversation with Dr Gary Waanders Director of Healthcare Research at Zeus Capital. Since Allergy Therapeutics announced today that it has obtained approval..
Zeus Capital Director of Healthcare Research Dr Gary Waanders caught up with DirectorsTalk for an exclusive interview to discuss Oncimmune Holdings PLC (LON:ONC) Q1: This morning Oncimmune released its..
Oncimmune Holdings Plc (LON:ONC) is the topic of conversation when Dr Gary Waanders the Director of Healthcare Research at Zeus Capital caught up with DirectorsTalk. Gary talks us through the..
Zeus Capital Research Director Dr Tom McColm caught up with DirectorsTalk for an exclusive interview to discuss Ceres Power Holdings plc (LON:CWR) Q1: Tom, what are your thoughts on..
Ceres Power Holdings plc (LON:CWR) CEO Phil Caldwell chats with DirectorsTalk about it’s latest trading update. Phil talks about the last 6 months, opportunities for the company, the effects of..
Zeus Capital Healthcare Research Director Dr Gary Waanders caught up with DirectorsTalk for an exclusive interview to discuss Allergy Therapeutics plc (LON:AGY) Q1: Allergy Therapeutics plc H1 trading update..
Zeus Capital Healthcare Research Director Dr Gary Waanders caught up with DirectorsTalk for an exclusive interview to discuss Motif Bio PLC (LON:MTFB) Q1: Now, you updated your coverage on..
Allergy Therapeutics Plc (LON:AGY) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary explains whats driven growth..
Motif Bio Plc (LON:MTFB) is the topic of conversation when DirectorsTalk caught up with Dr Gary Waanders the Director of Healthcare Research at Zeus Capital. Gary covers the highlights for..
Zeus Capital Research Director Robin Savage caught up with DirectorsTalk for an exclusive interview to discuss City of London Investment Group PLC (LON:CLIG) Q1: Now Robin, this morning City..
Zeus Capital Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview to discuss Elegant Hotels Group PLC (LON:EHG) Q1: Mike, Elegant Hotels Group PLC, can..
City of London Investment Group Plc (LON:CLIG) is the topic of conversation with Robin Savage, research director at Zeus Capital. Robin explains why a 61% increase in its profit before..
Elegant Hotels Group Plc (LON:EHG) is the topic of discussion with Mike Allen, head of research at Zeus Capital. Mike explains his take on the 2016 results, talks about key..
Zeus Capital Healthcare Research Director Dr Gary Waanders caught up with DirectorsTalk for an exclusive interview to discuss C4X Discovery Holdings PLC (LON:C4XD) Q1: Now, C4X Discovery released its..
C4X Discovery Holdings Plc (LON:C4XD) is the topic of discussion with Dr Gary Waanders, Healthcare Research Director at Zeus Capital. Gary, runs through the important highlights from the latest results..
Ilika plc (LON:IKA) interims today show the company is executing its solid-state battery commercialisation strategy as planned. We leave FY17 & FY18 forecasts unchanged and look for first OEM licensing..
